Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 03-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,030 | -1,770 | -780 | -2,690 | N/A |
| Depreciation Amortization | 40 | 20 | 10 | 30 | N/A |
| Other Working Capital | 340 | -780 | -190 | -180 | N/A |
| Other Operating Activity | 540 | -90 | -190 | -210 | 0 |
| Operating Cash Flow | $-3,110 | $-2,620 | $-1,150 | $-3,050 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -120 | -50 | -10 | -130 | N/A |
| Investing Cash Flow | $-120 | $-50 | $-10 | $-130 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 7,410 | 7,390 | 7,340 | 870 | 0 |
| Financing Cash Flow | $7,410 | $7,390 | $7,340 | $870 | $N/A |
| Beginning Cash Position | 2,420 | 2,420 | 2,420 | 7,810 | N/A |
| End Cash Position | 6,600 | 7,150 | 8,600 | 5,140 | N/A |
| Net Cash Flow | $4,170 | $4,720 | $6,180 | $-2,660 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,110 | -2,620 | -1,150 | -3,050 | N/A |
| Free Cash Flow | -3,110 | -2,620 | -1,150 | -3,050 | 0 |